A Study on the Development of China’s Market Exclusivity System for Rare Disease Drugs and Pediatric Medicines

A Study on the Development of China’s Market Exclusivity System for Rare Disease Drugs and Pediatric Medicines

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (9) : 6-21.

PDF(4286 KB)

PDF(4286 KB)

China Food Drug Administration ›› 2026, Vol. 0 ›› Issue (9) : 6-21. DOI: 10.3969/j.issn.1673-5390.2026.09.001

A Study on the Development of China’s Market Exclusivity System for Rare Disease Drugs and Pediatric Medicines

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 0(9): 6-21 https://doi.org/10.3969/j.issn.1673-5390.2026.09.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(4286 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉